Lisa Feng, DrPH (Board Liaison)

Lisa Feng, DrPH is the Senior Director of Health Policy at Alexion, AstraZeneca Rare Disease which focuses on transforming the lives of people affected by rare diseases and devastating conditions. In her role at Alexion, Dr. Feng helps the company assess the evolving health policy landscape to lead efforts that help ensure patient access to […]

Jennifer Houlihan, MSP

Jennifer serves as a vice president for enterprise population health focused on Medicaid and Medicare value-based care policy and programming and integration of the enterprise population health platform with the academic core of Advocate Health. Jennifer is focused on executing aligned learning health system priorities including serving as a member of Wake Forest School of […]

Richie Kahn, MPH

A health policy professional by training, clinical researcher by trade and patient advocate by necessity, Richie Kahn has spent the last 15 years working across the industry to reduce the time it takes to bring promising new treatments to the patients that need them most. As Co-Founder & COO of Canary Advisors, Richie partners with […]

Nitzan Arad, LLM

Nitzan Arad is an Area Lead for Drug Pricing with the Duke-Margolis Institute for Health Policy. Her work focuses on drug pricing and payment reforms, primarily in Medicare and Medicaid. Before joining Duke-Margolis, she was a Director of Public Policy at Teva Pharmaceuticals, where she led research and analysis on a variety of government pricing […]

Fauzea Hussain, MPH

Fauzea Hussain is the Vice President of Public Policy at McKesson, where she champions innovative public policy strategies that drive the company’s mission to improve health outcomes for all. With a keen focus on patient-first solutions, Fauzea collaborates across the McKesson enterprise to address the diverse needs of distributors, wholesalers, community providers, health systems, pharmacies, […]

Claire Sachs, MA

Claire is a federal health policy and communications specialist whose personal health history goes back to the early 1980s. Since then, she has managed a raft of serious conditions, both acute and chronic. She has also been a caregiver for both chronically ill and terminally ill family members. A few years ago, Claire realized her […]

Anna Hyde, MA

Anna Hyde is the Vice President of Advocacy and Access at the Arthritis Foundation. She oversees both the federal and state legislative programs, in addition to grassroots engagement. Her focus is to raise the visibility of arthritis as a public health priority, build support for federal and state legislation that ensure access to affordable, high-quality […]

Greg Daniel, PhD, MPH

Greg has 20 years of distinguished experience in healthcare policy and research. As a recognized health policy leader, Greg spent almost a decade leading pharmaceutical and medical device policy in the areas of value-based healthcare and payment, real-world evidence development, and FDA regulatory science. Prior to joining Edwards, Greg was the Deputy Center Director at […]